中国寄生虫学与寄生虫病杂志 ›› 2014, Vol. 32 ›› Issue (4): 7-280-284.

• 论著 • 上一篇    下一篇

粉尘螨Ⅲ类重组变应原对哮喘小鼠免疫治疗的效果

李娜1,姜玉新2,刁吉东1,赵蓓蓓1,李朝品1*   

  1. 皖南医学院,1 寄生虫学教研室;2 生理学教研室,芜湖 241002
  • 出版日期:2014-08-30 发布日期:2014-10-31

Effect of Immunotherapy with Recombinant Allergen Group 3 from Dermatophagoides farinae in Asthma Mice

LI Na1,JIANG Yu-xin2,DIAO Ji-dong1,ZHAO Bei-bei1,LI Chao-pin1*   

  1. 1 Department of Medical Parasitology,2 Department of Physiology,Wannan Medical College,Wuhu 241002,China
  • Online:2014-08-30 Published:2014-10-31

摘要:

目的  探讨粉尘螨Ⅲ类重组变应原(rDer f 3)对过敏性哮喘小鼠的免疫治疗效果。 方法 随机将40只BALB/c小鼠均分为4组,哮喘组、免疫治疗组、卵清蛋白(OVA)组和PBS组,分别在第0、第7和第14天哮喘组和免疫治疗组每鼠经腹腔注射100 μl致敏液(含rDer f 3 10 μg);卵清蛋白组每鼠经腹腔注射100 μl致敏液(含OVA 10 μg);PBS组则以PBS代替致敏液。第21天起,哮喘组和免疫治疗组小鼠用rDer f 3进行滴鼻激发试验,连续7 d,免疫治疗组小鼠在第25~27天滴鼻激发前30 min,用100 μg rDer f 3纯化蛋白皮下注射进行特异性免疫治疗。PBS组和卵清蛋白组则分别用PBS和OVA进行滴鼻激发和腹腔注射,最后1次滴鼻激发24 h后脱臼处死小鼠。收集各组小鼠支气管肺泡灌洗液(BALF)进行白细胞和嗜酸粒细胞计数;对肺组织病理切片进行HE染色,镜下观察肺组织炎症细胞浸润情况。ELISA检测BALF和脾细胞培养上清(SSCS)中白细胞介素-5(IL-5)和γ干扰素(IFN-γ)及血清中变应原特异性IgE、IgG2a抗体水平。 结果  肺组织病理切片结果显示,免疫治疗组小鼠炎症反应明显减轻。小鼠BALF中白细胞总数在免疫治疗组、卵清蛋白组和哮喘组分别为(7.03±1.38)×108/ml、(22.11±3.70)×108/ml和(22.75±3.24)×108/ml,免疫治疗组低于卵清蛋白组和哮喘组(P<0.01),嗜酸粒细胞的变化趋势与白细胞类似。免疫治疗组、卵清蛋白组和哮喘组BALF中IL-5的水平分别为(108.20±11.02)pg/ml、(182.04±13.94)pg/ml和(195.33±15.33)pg/ml,SSCS中IL-5的水平分别为(98.34±13.06)pg/ml、(208.26±10.63)pg/ml和(179.54±13.65)pg/ml,免疫治疗组均明显低于卵清蛋白组和哮喘组(P<0.01)。而IFN-γ含量则高于卵清蛋白组和哮喘组(P<0.01)。IgE水平免疫治疗组、卵清蛋白组和哮喘组分别为(9.12±3.78)IU/ml、(26.87±4.30)IU/ml和(35.25±8.84)IU/ml,与卵清蛋白组和哮喘组相比,免疫治疗组明显降低(P<0.01),而IgG2a水平(38.52±6.33)μg/ml则显著升高(P<0.01)。 结论 粉尘螨Ⅲ类变应原可逆转哮喘小鼠的变态反应性气道及肺部炎症。

关键词:  ,  粉尘螨;Der f 3;变应原;哮喘;免疫治疗

Abstract:

Objective  To explore the effect of specific immunotherapy with major 3 group recombinant allergen rDer f 3 of Dermatophagoides farinae in murine asthma model.  Methods  Forty BALB/c mice were randomly divided into 4 groups, namely PBS group(negative control), ovalbumin(OVA) group(positive control), rDer f 3 allergen sensitization group(asthma group), and rDer f 3 specific immunotherapy group(SIT group). The mice in asthma group and SIT group were injected intraperitoneally with purified rDer f 3 protein on days 0, 7 and 14, respectively, and rDer f 3 solution was inhalated from day 21 for 7 days. During the 25th-27th day, mice in SIT group were injected subcutaneously with 100 μg rDer f 3 allergen for 30 min before nasal inhalation. Mice in groups of PBS and OVA were treated with PBS and OVA, respectively. Twenty-four hours after the final challenge, all mice were sacrificed, the bronchoalveolar lavage fluid(BALF) was collected and the total number of white blood cells and the number of eosinophils were recorded. The levels of IL-5 and IFN-γ in BALF and supernatant of cultured splenocytes were detected by ELISA, as well as the serum levels of specific IgE and IgG2a antibodies. Lung tissues were stained with haematoxylin and eosin for histological analysis.  Results  Compared with the asthma group, the rDer f 3-induced lung inflammation was significantly alleviated in SIT group. The total number of white blood cells[(7.03±1.38)×108/ml] in SIT group was considerably lower than that of OVA group[(22.11±3.70)×108/ml] and asthma group[(22.75±3.24)×108/ml](P<0.01). The change trend of eosinophil leukocytes was similar with that of white blood cells. IL-5 levels in BALF[(108.20±11.02) pg/ml] and splenocyte culture supernatant [(98.34±13.06) pg/ml] in SIT group were significantly lower than that of OVA group[(182.04±13.94) pg/ml,(208.26±10.63) pg/ml] and asthma group[(195.33±15.33) pg/ml,(179.54±13.65) pg/ml](P<0.01). Whereas, the level of IFN-γ in BALF[(107.98±12.64) pg/ml] and supernatant of cultured splenocytes[(105.51±11.62) pg/ml] in SIT group was significantly higher than those of OVA group and asthma group(P<0.01). Compared with OVA group[(26.87±4.30)IU/ml] and asthma group[(35.25±8.84)IU/ml], a lower level of allergen-specific IgE[(9.12±3.78)IU/ml] and higher level of allergen-specific IgG2a[(38.52±6.33) μg/ml] were observed in SIT group(P<0.01).  Conclusion  rDer f 3 allergen can reverse allergen-induced airway and lung inflammation in murine asthma model.

Key words: Dermatophagoides farinae, Der f 3, Allergen, Asthma, Specific allergen immunotherapy